The Implications of Suboptimal Treatment Outcomes with Disease-Modifying Drugs in Employees with Multiple Sclerosis Jul 7, 2020
Comparing costs and absences for Multiple Sclerosis among US employees: pre- and post-treatment initiation Mar 1, 2020
Medication adherence with disease modifying treatments for multiple sclerosis among US employees Mar 1, 2020
